Guenter Mueller
26Patents
4h-index
37Co-inventors
63Inventor score
Filing activity: Dec 8, 1980 → Nov 9, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7265111B2 | Adenosine analogues and their use as pharmaceutical agents | Chemistry; Metallurgy | 81 | Expired |
| US6599473B1 | Electrochemilumiscence method for detecting analytes | Emerging Cross-Sectional Technologies | 17 | Expired |
| US6004938A | Inositolglycans having insulin-like action | Chemistry; Metallurgy | 11 | Expired |
| US7727989B2 | 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments | Chemistry; Metallurgy | 4 | Active |
| US4491674A | Process and apparatus for the safe supply of molecular oxygen or of gas containing molecular oxygen to an oxidation of hydrocarbons | Chemistry; Metallurgy | 4 | Expired |
| US6566390B2 | Substituted and unsubstituted benzooxathiazoles and compounds derived therefrom | Chemistry; Metallurgy | 3 | Expired |
| US7244821B2 | Use of Saccharomyces cerevisiae erg4 mutants for expressing mammalian glucose transporters | Human Necessities | 2 | Expired |
| US7449560B2 | Phosophoinositoglycan binding proteins | Human Necessities | 2 | Active |
| US7049416B2 | Phosophoinositoglycan binding proteins | Human Necessities | 2 | Expired |
| US7094794B2 | Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use | Chemistry; Metallurgy | 2 | Expired |
| US7615360B2 | Use of Saccharomyces cerevisiae erg4 mutants for expressing mammalian glucose transporter | Human Necessities | 1 | Active |
| US6369088B2 | Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use as pharmaceuticals | Chemistry; Metallurgy | 1 | Expired |
| US7709466B2 | Pyridazinone derivatives, methods for their production and their use as pharmaceuticals | Chemistry; Metallurgy | 1 | Active |
| US6596742B1 | Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use in medicaments | Human Necessities | 1 | Expired |
| US8580251B2 | PIM-3 kinase as a target for type 2 diabetes mellitus | Chemistry; Metallurgy | 0 | Active |
| US7737144B2 | Pyrimido[5,4-e][1,2,4]triazine-5-7-diones, processes for preparing them and their use | Human Necessities | 0 | Active |
| US7741491B2 | Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1B (PTB1B) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes | Chemistry; Metallurgy | 0 | Active |
| US7781613B2 | Substituted N-aminomethylene sulfonamides, production and use thereof as medicaments | Chemistry; Metallurgy | 0 | Active |
| US8298812B2 | Use of Saccharomyces cerevisiae erg4 mutants for expressing mammalian glucose transporters | Human Necessities | 0 | Active |
| US6596518B2 | Percyquinnin, a process for its production and its use as a pharmaceutical | Chemistry; Metallurgy | 0 | Expired |
| US7208504B2 | Bicyclic inhibitors of hormone sensitive lipase | Chemistry; Metallurgy | 0 | Expired |
| US7629126B2 | PIM-3 kinase as a target for type 2 diabetes mellitus | Chemistry; Metallurgy | 0 | Active |
| US8574909B2 | Saccharomyces cerevisiae yeast strain with functional expression of a GLUT transporter gene | Chemistry; Metallurgy | 0 | Active |
| US7211592B2 | Substituted an unsubstituted benzooxathiazoles and compounds derived therefrom | Chemistry; Metallurgy | 0 | Expired |
| US8017350B2 | Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase C regulation | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.